Wan , X., Zeng, Y., Xiong, M., Chen, L., & Bai, Y. (2026). FCGBP inhibits the development of LSCC and cisplatin resistance through the PIGR/JAK2/STAT3 pathway. Radiology and Oncology, 60(1), 67–75. Retrieved from https://radioloncol.com/index.php/ro/article/view/4672